<DOC>
	<DOCNO>NCT02599012</DOCNO>
	<brief_summary>- Multifactorial pathogenesis involve anemia cancer patient define cause anemia always simple . - Currently , treatment option available anemia cancer patient include red blood cell ( RBC ) transfusion , erythropoietin stimulating agent ( ESA ) , iron supplementation , accompany considerable pros con treatment . - Previous study demonstrate benefit treat IV iron combination ESA , recently , evidence emerge suggest role IV iron alone . - In study , investigator ass efficacy intravenous iron treatment anemia cancer patient .</brief_summary>
	<brief_title>The Efficacy Intravenous Iron Treatment Anemia Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<criteria>Subjects diagnose solid cancer lymphoma Subjects anticancer therapy enrollment finish anticancer therapy within 2 month enrollment anticancer therapy : `` chemotherapy '' , and/or `` chemotherapy + radiotherapy '' , and/or `` target agent '' Subjects whose Hb level 8.010.5g/dL , experience drop Hb 2g/dL anticancer treatment Subjects receive iron ( oral iv ) , ESA , dialysis within 4 week enrollment Subjects uncontrolled infection Subjects ongoing bleeding Deteriorated organ function poor performance state ( ECOG 34 ) Subjects whose disease involve bone marrow Ferritin &gt; 800 ng/ml Transferrin saturation ( TSAT ) â‰¥ 50 %</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>